Judah Frommer
Stock Analyst at Morgan Stanley
(4.24)
# 1,407
Out of 4,463 analysts
458
Total ratings
56.4%
Success rate
7.1%
Average return
Main Sectors:
Stocks Rated by Judah Frommer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Maintained: Hold | n/a | $13.30 | - | 13 | Jun 29, 2026 | |
| EVMN Evommune | Maintained: Buy | $55 → $26 | $13.29 | +95.64% | 8 | Jun 29, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $119 | $114.67 | +3.78% | 11 | Jun 25, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $16 | $11.98 | +33.56% | 20 | Jun 24, 2026 | |
| ENGN enGene Therapeutics | Downgraded: Sell | n/a | $1.73 | - | 9 | Jun 18, 2026 | |
| INCY Incyte | Maintained: Hold | $103 | $113.36 | -9.14% | 11 | Jun 15, 2026 | |
| CLDX Celldex Therapeutics | Maintained: Buy | $44 | $37.21 | +18.25% | 9 | Jun 12, 2026 | |
| AVLN Avalyn Pharma | Maintained: Buy | $53 | $32.92 | +61.00% | 2 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Rated: Buy | $145 → $132 | $133.26 | -0.95% | 6 | Jun 2, 2026 | |
| PROK ProKidney | Rated: Hold | $3 | $2.04 | +47.06% | 14 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $11 | $12.98 | -18.72% | 4 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $17 | $14.15 | +20.14% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $22 | $25.38 | -13.32% | 11 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.07 | +243.98% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $37 | $29.69 | +24.62% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $92 → $94 | $81.57 | +15.24% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $33 | $27.47 | +20.13% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $34 | $26.22 | +29.67% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $20 | $18.65 | +7.24% | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $10.31 | +93.99% | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $22 | $29.98 | -26.62% | 50 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $191 → $201 | $153.99 | +30.53% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $141 → $139 | $17.97 | n/a | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $0.0006 | n/a | 9 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.90 | n/a | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.421 | n/a | 8 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $5.27 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $32.72 | n/a | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $22 | $33.89 | n/a | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $10.30 | n/a | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $2.67 | n/a | 4 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $8 | $3.66 | n/a | 9 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $6 → $7 | $3.16 | n/a | 10 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $55 | $46.06 | n/a | 6 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $46 | $106.62 | n/a | 3 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3.5 | $18.19 | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $102.25 | n/a | 7 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $26 | $84.58 | n/a | 10 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $13.53 | n/a | 2 | Jul 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $95 | $76.88 | n/a | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $328 | $935.47 | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $55.53 | n/a | 28 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $116 | $179.79 | n/a | 9 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 → €24.00 | $34.94 | n/a | 3 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $107 | $120.95 | n/a | 19 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $154 → $178 | $115.11 | n/a | 10 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $38 | $87.22 | n/a | 4 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $63 | $83.58 | n/a | 17 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $111.79 | n/a | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $21.11 | n/a | 1 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $40.26 | n/a | 1 | Mar 6, 2019 |
4D Molecular Therapeutics
Jun 29, 2026
Maintained: Hold
Price Target: n/a
Current: $13.30
Upside: -
Evommune
Jun 29, 2026
Maintained: Buy
Price Target: $55 → $26
Current: $13.29
Upside: +95.64%
Kymera Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: $119
Current: $114.67
Upside: +3.78%
REGENXBIO
Jun 24, 2026
Maintained: Buy
Price Target: $16
Current: $11.98
Upside: +33.56%
enGene Therapeutics
Jun 18, 2026
Downgraded: Sell
Price Target: n/a
Current: $1.73
Upside: -
Incyte
Jun 15, 2026
Maintained: Hold
Price Target: $103
Current: $113.36
Upside: -9.14%
Celldex Therapeutics
Jun 12, 2026
Maintained: Buy
Price Target: $44
Current: $37.21
Upside: +18.25%
Avalyn Pharma
Jun 3, 2026
Maintained: Buy
Price Target: $53
Current: $32.92
Upside: +61.00%
ABIVAX Société Anonyme
Jun 2, 2026
Rated: Buy
Price Target: $145 → $132
Current: $133.26
Upside: -0.95%
ProKidney
May 18, 2026
Rated: Hold
Price Target: $3
Current: $2.04
Upside: +47.06%
May 18, 2026
Maintained: Buy
Price Target: $28 → $11
Current: $12.98
Upside: -18.72%
May 14, 2026
Rated: Buy
Price Target: $16 → $17
Current: $14.15
Upside: +20.14%
May 14, 2026
Maintained: Hold
Price Target: $21 → $22
Current: $25.38
Upside: -13.32%
May 13, 2026
Maintained: Buy
Price Target: $14
Current: $4.07
Upside: +243.98%
May 12, 2026
Rated: Buy
Price Target: $36 → $37
Current: $29.69
Upside: +24.62%
May 8, 2026
Maintained: Buy
Price Target: $92 → $94
Current: $81.57
Upside: +15.24%
May 8, 2026
Maintained: Hold
Price Target: $34 → $33
Current: $27.47
Upside: +20.13%
May 7, 2026
Maintained: Buy
Price Target: $35 → $34
Current: $26.22
Upside: +29.67%
May 5, 2026
Rated: Buy
Price Target: $18 → $20
Current: $18.65
Upside: +7.24%
Mar 26, 2026
Rated: Buy
Price Target: $20
Current: $10.31
Upside: +93.99%
Mar 16, 2026
Maintained: Sell
Price Target: $22
Current: $29.98
Upside: -26.62%
Mar 3, 2026
Maintained: Buy
Price Target: $191 → $201
Current: $153.99
Upside: +30.53%
Aug 3, 2023
Maintained: Hold
Price Target: $141 → $139
Current: $17.97
Upside: n/a
Jun 5, 2023
Maintained: Buy
Price Target: $138
Current: $0.0006
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $13
Current: $5.90
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $40
Current: $0.421
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $9
Current: $5.27
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $28
Current: $32.72
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $21 → $22
Current: $33.89
Upside: n/a
Mar 31, 2023
Maintained: Buy
Price Target: $8 → $7
Current: $10.30
Upside: n/a
Mar 28, 2023
Maintained: Buy
Price Target: $16 → $13
Current: $2.67
Upside: n/a
Mar 9, 2023
Downgraded: Hold
Price Target: $11 → $8
Current: $3.66
Upside: n/a
Mar 7, 2023
Upgraded: Hold
Price Target: $6 → $7
Current: $3.16
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $51 → $55
Current: $46.06
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $57 → $46
Current: $106.62
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $3.5
Current: $18.19
Upside: n/a
Aug 4, 2020
Maintained: Buy
Price Target: $23 → $24
Current: $102.25
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $22 → $26
Current: $84.58
Upside: n/a
Jul 27, 2020
Maintained: Buy
Price Target: $18
Current: $13.53
Upside: n/a
Jul 22, 2020
Rated: Hold
Price Target: $90 → $95
Current: $76.88
Upside: n/a
Jul 8, 2020
Maintained: Hold
Price Target: $328
Current: $935.47
Upside: n/a
Jun 18, 2020
Maintained: Hold
Price Target: $35
Current: $55.53
Upside: n/a
Jun 10, 2020
Rated: Buy
Price Target: $125 → $116
Current: $179.79
Upside: n/a
Jun 3, 2020
Maintained: Hold
Price Target: €22.00 → €24.00
Current: $34.94
Upside: n/a
May 28, 2020
Rated: Buy
Price Target: $98 → $107
Current: $120.95
Upside: n/a
May 22, 2020
Maintained: Hold
Price Target: $154 → $178
Current: $115.11
Upside: n/a
May 21, 2020
Rated: Buy
Price Target: $31 → $38
Current: $87.22
Upside: n/a
May 5, 2020
Rated: Buy
Price Target: $67 → $63
Current: $83.58
Upside: n/a
May 4, 2020
Maintained: Buy
Price Target: $39
Current: $111.79
Upside: n/a
Mar 6, 2020
Downgraded: Hold
Price Target: n/a
Current: $21.11
Upside: n/a
Mar 6, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $40.26
Upside: n/a